Financial report interval: 2025.12.31 - 2026.03.31
Overview: ENWEI PHARMACEUTICAL(301331) the Revenue is 175.33 M (-10.77%);the EBIT is 12.47 M (-14.08%);the EPS is 0.121 (-25.69%).